Longitude Health Adds Two New Utilities as Portfolio Growth Accelerates
Clinical Trial Services and Longitude Cell and Gene Therapy Approved by Board; Thad Wolfram and Sinthu Sinnadurai Named Executives WASHINGTON, July 21, 2026 /PRNewswire/ -- Longitude Health announced its Board of Managers approved funding for two new utilities, Longitude Clinical Trial...
Clinical Trial Services and Longitude Cell and Gene Therapy Approved by Board; Thad Wolfram and Sinthu Sinnadurai Named Executives WASHINGTON, July 21, 2026 /PRNewswire/ -- Longitude Health announced its Board of Managers approved funding for two new utilities, Longitude Clinical Trial...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.